These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 26347099)

  • 1. Reply to the letter to the editor 'new life for retrospective study in the precision oncology era' by Orlandi et al.
    Pietrantonio F; Cremolini C
    Ann Oncol; 2015 Nov; 26(11):2353. PubMed ID: 26347099
    [No Abstract]   [Full Text] [Related]  

  • 2. New life for retrospective study in the precision oncology era.
    Orlandi A; Basso M; Calegari MA; Barone C
    Ann Oncol; 2015 Nov; 26(11):2352-3. PubMed ID: 26347104
    [No Abstract]   [Full Text] [Related]  

  • 3. BRAF codons 594 and 596 mutations identify a new molecular subtype of metastatic colorectal cancer at favorable prognosis.
    Cremolini C; Di Bartolomeo M; Amatu A; Antoniotti C; Moretto R; Berenato R; Perrone F; Tamborini E; Aprile G; Lonardi S; Sartore-Bianchi A; Fontanini G; Milione M; Lauricella C; Siena S; Falcone A; de Braud F; Loupakis F; Pietrantonio F
    Ann Oncol; 2015 Oct; 26(10):2092-7. PubMed ID: 26153495
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The survival outcome of patients with metastatic colorectal cancer based on the site of metastases and the impact of molecular markers and site of primary cancer on metastatic pattern.
    Prasanna T; Karapetis CS; Roder D; Tie J; Padbury R; Price T; Wong R; Shapiro J; Nott L; Lee M; Chua YJ; Craft P; Piantadosi C; Sorich M; Gibbs P; Yip D
    Acta Oncol; 2018 Nov; 57(11):1438-1444. PubMed ID: 30035653
    [TBL] [Abstract][Full Text] [Related]  

  • 5. How can we identify new biomarkers for patients with for lung metastasectomy in colorectal cancer.
    Renaud S; Falcoz PE
    Future Oncol; 2015; 11(15):2109-11. PubMed ID: 26235176
    [No Abstract]   [Full Text] [Related]  

  • 6. High concordance rate of KRAS/BRAF mutations and MSI-H between primary colorectal cancer and corresponding metastases.
    Fujiyoshi K; Yamamoto G; Takahashi A; Arai Y; Yamada M; Kakuta M; Yamaguchi K; Akagi Y; Nishimura Y; Sakamoto H; Akagi K
    Oncol Rep; 2017 Feb; 37(2):785-792. PubMed ID: 28000889
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reply: Comment on 'KRAS and BRAF mutations are prognostic biomarkers in patients undergoing lung metastasectomy of colo-rectal cancer'.
    Renaud S; Falcoz PE; Romain B; Olland A; Santelmo N; Brigand C; Rohr S; Guenot D; Massard G
    Br J Cancer; 2015 Dec; 113(11):1637-8. PubMed ID: 26372702
    [No Abstract]   [Full Text] [Related]  

  • 8. Colorectal carcinomas with KRAS codon 12 mutation are associated with more advanced tumor stages.
    Li W; Qiu T; Zhi W; Shi S; Zou S; Ling Y; Shan L; Ying J; Lu N
    BMC Cancer; 2015 May; 15():340. PubMed ID: 25929517
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Value of KRAS, BRAF, and PIK3CA Mutations and Survival Benefit from Systemic Chemotherapy in Colorectal Peritoneal Carcinomatosis.
    Sasaki Y; Hamaguchi T; Yamada Y; Takahashi N; Shoji H; Honma Y; Iwasa S; Okita N; Takashima A; Kato K; Nagai Y; Taniguchi H; Boku N; Ushijima T; Shimada Y
    Asian Pac J Cancer Prev; 2016; 17(2):539-43. PubMed ID: 26925640
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The forest and the trees: pathways and proteins as colorectal cancer biomarkers.
    Bertagnolli MM
    J Clin Oncol; 2009 Dec; 27(35):5866-7. PubMed ID: 19884524
    [No Abstract]   [Full Text] [Related]  

  • 11. Perioperative bevacizumab improves survival following lung metastasectomy for colorectal cancer in patients harbouring v-Ki-ras2 Kirsten rat sarcoma viral oncogene homologue exon 2 codon 12 mutations†.
    Renaud S; Schaeffer M; Falcoz PE; Seitlinger J; Romain B; Voegeli AC; Legrain M; Reeb J; Santelmo N; Rohr S; Brigand C; Olland A; Guenot D; Massard G
    Eur J Cardiothorac Surg; 2017 Feb; 51(2):255-262. PubMed ID: 28186237
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Don't abandon BRAF-mutated patients with peritoneal metastasis! Re: « Therapeutic implications of B-RAF mutations in colorectal cancer ».
    Noiret B; Piessen G; Eveno C
    J Visc Surg; 2022 Feb; 159(1):85. PubMed ID: 34802948
    [No Abstract]   [Full Text] [Related]  

  • 13. The role of K-RAS and B-RAF mutations as biomarkers in metastatic colorectal cancer.
    Selcukbiricik F; Erdamar S; Ozkurt CU; Molinas Mandel N; Demirelli F; Ozguroglu M; Tural D; Buyukunal E; Serdengecti S
    J BUON; 2013; 18(1):116-23. PubMed ID: 23613396
    [TBL] [Abstract][Full Text] [Related]  

  • 14. EGFR, BRAF and KRAS status in patients undergoing pulmonary metastasectomy from primary colorectal carcinoma: a prospective follow-up study.
    Schweiger T; Hegedüs B; Nikolowsky C; Hegedüs Z; Szirtes I; Mair R; Birner P; Döme B; Lang G; Klepetko W; Ankersmit HJ; Hoetzenecker K
    Ann Surg Oncol; 2014 Mar; 21(3):946-54. PubMed ID: 24281417
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Axillary Lymph Node Involvement, a Unique Pattern of Metastasis in BRAF-Mutant Colorectal Cancer.
    Lipsyc MD; Yaeger R; Dengel LT; Saltz L
    JAMA Oncol; 2015 Aug; 1(5):686-7. PubMed ID: 26182332
    [No Abstract]   [Full Text] [Related]  

  • 16. Associations between primary tumor RAS, BRAF and PIK3CA mutation status and metastatic site in patients with chemo-resistant metastatic colorectal cancer.
    Christensen TD; Palshof JA; Larsen FO; Poulsen TS; Høgdall E; Pfeiffer P; Jensen BV; Yilmaz MK; Nielsen D
    Acta Oncol; 2018 Aug; 57(8):1057-1062. PubMed ID: 29380640
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Novel multiple, monoallelic KRAS mutations at codon 12 and 13.
    Keller G; Geist B; Slotta-Huspenina J; Langer R; Nagl F; Fend F; Höfler H; Perren A
    Int J Cancer; 2009 Dec; 125(11):2744-5. PubMed ID: 19521964
    [No Abstract]   [Full Text] [Related]  

  • 18. Beyond KRAS: a new approach in metastatic colorectal cancer.
    Winder T; Lenz HJ
    Lancet Oncol; 2010 Aug; 11(8):706-7. PubMed ID: 20619738
    [No Abstract]   [Full Text] [Related]  

  • 19. The unfulfilled promise of molecular diagnosis in colorectal cancer.
    Golfinopoulos V; Hendlisz A
    Curr Opin Oncol; 2010 Jul; 22(4):362-3. PubMed ID: 20473163
    [No Abstract]   [Full Text] [Related]  

  • 20. KRAS and BRAF mutations are prognostic biomarkers in patients undergoing lung metastasectomy of colorectal cancer.
    Renaud S; Romain B; Falcoz PE; Olland A; Santelmo N; Brigand C; Rohr S; Guenot D; Massard G
    Br J Cancer; 2015 Feb; 112(4):720-8. PubMed ID: 25688918
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.